• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM

IMMUTEP LIMITED - Announcements

0.00% ! 26.0¢
Market Cap $381.6M  !

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



IMM Immutep announces European Patent Grant for LAG525PRICE SENSITIVE07/04/21 download Created with Sketch. 230.25KB
IMM Change in substantial holding01/04/21 download Created with Sketch. 1.9MB
IMM Appendix 2A18/03/21 download Created with Sketch. 235.94KB
IMM Immutep collaborates with MSD for phase 2b head & neck trialPRICE SENSITIVE16/03/21 download Created with Sketch. 274.62KB
IMM S&P DJI Announces March 2021 Quarterly RebalancePRICE SENSITIVE12/03/21 download Created with Sketch. 183.24KB
IMM Immutep secures second US patent grant for eftilagimod alphaPRICE SENSITIVE09/03/21 download Created with Sketch. 231.9KB
IMM Immutep expands Part B of TACTI-002 collaboration trialPRICE SENSITIVE05/03/21 download Created with Sketch. 293.47KB
IMM Half Yearly Report and AccountsPRICE SENSITIVE23/02/21 download Created with Sketch. 594.81KB
IMM Immutep Corporate Presentation02/02/21 download Created with Sketch. 2.31MB
IMM Phase II study for eftilagimod alpha in COVID-19 advancesPRICE SENSITIVE27/01/21 download Created with Sketch. 253.86KB
IMM Immutep Quarterly Activities Report & Appendix 4CPRICE SENSITIVE22/01/21 download Created with Sketch. 504.63KB
IMM Ulcerative Colitis Phase II Study of GSK2831781 DiscontinuedPRICE SENSITIVE22/01/21 download Created with Sketch. 277.31KB
IMM Recruitment of head & neck cancer patients completed for ph2PRICE SENSITIVE07/01/21 download Created with Sketch. 226.01KB
IMM Resignation and Appointment of Joint Company Secretary04/01/21 download Created with Sketch. 228.09KB
IMM Change in substantial holding04/01/21 download Created with Sketch. 193.79KB
IMM Appendix 2A31/12/20 download Created with Sketch. 285.8KB
IMM Change in substantial holding31/12/20 download Created with Sketch. 1.9MB
IMM Change in substantial holding30/12/20 download Created with Sketch. 1.64MB
IMM Immutep granted US patent for eftilagimod alpha with a PD-1PRICE SENSITIVE30/12/20 download Created with Sketch. 235.36KB
IMM Change in substantial holding29/12/20 download Created with Sketch. 1.64MB
IMM Change of Director's Interest Notice - Dr Howard24/12/20 download Created with Sketch. 154.34KB
IMM Appendix 2A24/12/20 download Created with Sketch. 237.49KB
IMM Becoming a substantial holder24/12/20 download Created with Sketch. 1.58MB
IMM Change in substantial holding18/12/20 download Created with Sketch. 1.9MB
IMM Change in substantial holding17/12/20 download Created with Sketch. 1.07MB
IMM Immutep Upscales Efti ManufacturingPRICE SENSITIVE16/12/20 download Created with Sketch. 271.36KB
IMM Change in substantial holding16/12/20 download Created with Sketch. 1.89MB
IMM Operational UpdatePRICE SENSITIVE15/12/20 download Created with Sketch. 255.39KB
IMM Ceasing to be a substantial holder15/12/20 download Created with Sketch. 396.12KB
IMM Change in substantial holding15/12/20 download Created with Sketch. 1.9MB
IMM Appendix 2A11/12/20 download Created with Sketch. 285.65KB
IMM Webcast slides for AIPAC Phase IIb breast cancer trial11/12/20 download Created with Sketch. 2.02MB
IMM Immutep's partner EOC pharma to start Ph II trial in MBCPRICE SENSITIVE10/12/20 download Created with Sketch. 280.1KB
IMM Overall Survival data from ph IIb AIPAC breast cancer trialPRICE SENSITIVE10/12/20 download Created with Sketch. 394.58KB
IMM Change in substantial holding from AEF27/11/20 download Created with Sketch. 212.98KB
IMM Change in substantial holding27/11/20 download Created with Sketch. 1.07MB
IMM Cleansing Notice25/11/20 download Created with Sketch. 190.74KB
IMM Change of substantial holding from AEF24/11/20 download Created with Sketch. 190.66KB
IMM Appendix 2A24/11/20 download Created with Sketch. 281.34KB
IMM Proposed issue of Securities - IMMPRICE SENSITIVE19/11/20 download Created with Sketch. 25.35KB
IMM Immutep Investor Presentation19/11/20 download Created with Sketch. 2.26MB
IMM Immutep completes a A$29.6 million placementPRICE SENSITIVE19/11/20 download Created with Sketch. 283.79KB
IMM Immutep expands TACTI-002 Collaboration Trial with MSDPRICE SENSITIVE19/11/20 download Created with Sketch. 242.02KB
IMM Change in substantial holding18/11/20 download Created with Sketch. 1.9MB
IMM Trading HaltPRICE SENSITIVE17/11/20 download Created with Sketch. 280.45KB
IMM Pause in TradingPRICE SENSITIVE17/11/20 download Created with Sketch. 114.67KB
IMM Encouraging Phase II TACTI-002 data reported at SITC 2020PRICE SENSITIVE10/11/20 download Created with Sketch. 366.98KB
IMM Immutep Announces Australian Patent Grant for IMP701PRICE SENSITIVE09/11/20 download Created with Sketch. 206.9KB
IMM Change of Director's Interest Notice - Grant Chamberlain06/11/20 download Created with Sketch. 294.56KB
IMM Appendix 3G06/11/20 download Created with Sketch. 292.87KB
IMM Proposed issue of Securities - IMM06/11/20 download Created with Sketch. 25.03KB
IMM Immutep to present TACTI-002 phase 2 data at SITC 202003/11/20 download Created with Sketch. 285.33KB
IMM Lapse of Unlisted Options02/11/20 download Created with Sketch. 243.77KB
IMM Immutep enters into a Licence & Collaboration with LabCorpPRICE SENSITIVE30/10/20 download Created with Sketch. 233.43KB
IMM Results of Meeting27/10/20 download Created with Sketch. 282.66KB
IMM Chairman's AGM Address27/10/20 download Created with Sketch. 206.53KB
IMM 2020 AGM PresentationPRICE SENSITIVE27/10/20 download Created with Sketch. 1.11MB
IMM COVID-19 phase 2 investigator initiated trial commencesPRICE SENSITIVE23/10/20 download Created with Sketch. 287.87KB
IMM Immutep Quarterly Activities Report & Appendix 4CPRICE SENSITIVE22/10/20 download Created with Sketch. 489.39KB
IMM Immutep granted European patent for IMP761PRICE SENSITIVE21/10/20 download Created with Sketch. 224.06KB
IMM Immutep to present AIPAC Overall Survival data at SABCS 202019/10/20 download Created with Sketch. 287.17KB
IMM Change in substantial holding06/10/20 download Created with Sketch. 1.08MB
IMM Change of Director's Interest Notice - Mr Chamberlain05/10/20 download Created with Sketch. 196.59KB
IMM Change of Director's Interest Notice - Mr Meyers05/10/20 download Created with Sketch. 204.34KB
IMM Change of Director's Interest Notice - Mr Voigt05/10/20 download Created with Sketch. 191.84KB
IMM Appendix 2A02/10/20 download Created with Sketch. 290.32KB
IMM Appendix 3G02/10/20 download Created with Sketch. 262.09KB
IMM Annual Report filed on Form 20-F with SEC28/09/20 download Created with Sketch. 758.16KB
IMM Notice of Annual General Meeting/Proxy Form25/09/20 download Created with Sketch. 1.12MB
IMM Appendix 4G & Corporate Governance Statement25/09/20 download Created with Sketch. 419.74KB
IMM Annual Report to shareholders25/09/20 download Created with Sketch. 1.74MB
IMM Immutep reports improving results from INSIGHT-004 trialPRICE SENSITIVE18/09/20 download Created with Sketch. 269.41KB
IMM Improving results from stage 1 of TACTI-002 ph II trialPRICE SENSITIVE18/09/20 download Created with Sketch. 281.8KB
IMM Change in substantial holding14/09/20 download Created with Sketch. 1.12MB
IMM 2020 AGM & Key Dates11/09/20 download Created with Sketch. 254.28KB
IMM IMM & Monash Uni receive funding grant for LAG-3 ResearchPRICE SENSITIVE31/08/20 download Created with Sketch. 264.06KB
IMM New data to be presented at ESMO for eftilagimod alpha26/08/20 download Created with Sketch. 307.71KB
IMM Appendix 4E & 2020 Full Year Statutory AccountsPRICE SENSITIVE25/08/20 download Created with Sketch. 1.19MB
IMM Recruitment of stage 1 of part B in TACTI-002 study completePRICE SENSITIVE18/08/20 download Created with Sketch. 243.59KB
IMM Immutep Investor Update17/08/20 download Created with Sketch. 1.44MB
IMM Immutep granted US patent for eftilagimod alphaPRICE SENSITIVE11/08/20 download Created with Sketch. 206.23KB
IMM Lapse of Unlisted Options11/08/20 download Created with Sketch. 231.32KB
IMM Change in substantial holding27/07/20 download Created with Sketch. 1.89MB
IMM Immutep Quarterly Activities Report & Appendix 4CPRICE SENSITIVE23/07/20 download Created with Sketch. 508.74KB
IMM Change in substantial holding21/07/20 download Created with Sketch. 1.9MB
IMM US patent granted for IMP701 antibodyPRICE SENSITIVE15/07/20 download Created with Sketch. 134.22KB
IMM Immutep Completes Recruitment for Part A of TACTI-002 trialPRICE SENSITIVE29/06/20 download Created with Sketch. 239.04KB
IMM Immutep receives A$1,437,826 R&D Tax IncentivePRICE SENSITIVE22/06/20 download Created with Sketch. 228.17KB
IMM Immutep announces improving data from TACTI-002 ph II trialPRICE SENSITIVE01/06/20 download Created with Sketch. 301.55KB
IMM Immutep Reports First Results from INSIGHT-004 StudyPRICE SENSITIVE01/06/20 download Created with Sketch. 270.11KB
IMM Immutep receives $3.6M R&D French tax incentivePRICE SENSITIVE29/05/20 download Created with Sketch. 252.82KB
IMM Immutep webcast to present new data from 2020 ASCO meeting27/05/20 download Created with Sketch. 266.15KB
IMM Becoming a substantial holder from AEF07/05/20 download Created with Sketch. 228.27KB
IMM Immutep granted Japanese patent for eftilagimod alphaPRICE SENSITIVE07/05/20 download Created with Sketch. 202.35KB
IMM Change in substantial holding07/05/20 download Created with Sketch. 177.48KB
IMM Cleansing Notice05/05/20 download Created with Sketch. 190.72KB
IMM Appendix 2A04/05/20 download Created with Sketch. 280.16KB
IMM Immutep presents at NWR Virtual Small Cap Health Conference01/05/20 download Created with Sketch. 239.47KB
IMM INSIGHT-004 and TACTI-002 data to be presented at ASCOPRICE SENSITIVE30/04/20 download Created with Sketch. 326.15KB
IMM Proposed issue of Securities - IMMPRICE SENSITIVE29/04/20 download Created with Sketch. 29.45KB
IMM Immutep announces European Patent Grant for LAG525
07/04/21PRICE SENSITIVE download Created with Sketch. 230.25KB
IMM Change in substantial holding
01/04/21 download Created with Sketch. 1.9MB
IMM Appendix 2A
18/03/21 download Created with Sketch. 235.94KB
IMM Immutep collaborates with MSD for phase 2b head & neck trial
16/03/21PRICE SENSITIVE download Created with Sketch. 274.62KB
IMM S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21PRICE SENSITIVE download Created with Sketch. 183.24KB
IMM Immutep secures second US patent grant for eftilagimod alpha
09/03/21PRICE SENSITIVE download Created with Sketch. 231.9KB
IMM Immutep expands Part B of TACTI-002 collaboration trial
05/03/21PRICE SENSITIVE download Created with Sketch. 293.47KB
IMM Half Yearly Report and Accounts
23/02/21PRICE SENSITIVE download Created with Sketch. 594.81KB
IMM Immutep Corporate Presentation
02/02/21 download Created with Sketch. 2.31MB
IMM Phase II study for eftilagimod alpha in COVID-19 advances
27/01/21PRICE SENSITIVE download Created with Sketch. 253.86KB
IMM Immutep Quarterly Activities Report & Appendix 4C
22/01/21PRICE SENSITIVE download Created with Sketch. 504.63KB
IMM Ulcerative Colitis Phase II Study of GSK2831781 Discontinued
22/01/21PRICE SENSITIVE download Created with Sketch. 277.31KB
IMM Recruitment of head & neck cancer patients completed for ph2
07/01/21PRICE SENSITIVE download Created with Sketch. 226.01KB
IMM Resignation and Appointment of Joint Company Secretary
04/01/21 download Created with Sketch. 228.09KB
IMM Change in substantial holding
04/01/21 download Created with Sketch. 193.79KB
IMM Appendix 2A
31/12/20 download Created with Sketch. 285.8KB
IMM Change in substantial holding
31/12/20 download Created with Sketch. 1.9MB
IMM Change in substantial holding
30/12/20 download Created with Sketch. 1.64MB
IMM Immutep granted US patent for eftilagimod alpha with a PD-1
30/12/20PRICE SENSITIVE download Created with Sketch. 235.36KB
IMM Change in substantial holding
29/12/20 download Created with Sketch. 1.64MB
IMM Change of Director's Interest Notice - Dr Howard
24/12/20 download Created with Sketch. 154.34KB
IMM Appendix 2A
24/12/20 download Created with Sketch. 237.49KB
IMM Becoming a substantial holder
24/12/20 download Created with Sketch. 1.58MB
IMM Change in substantial holding
18/12/20 download Created with Sketch. 1.9MB
IMM Change in substantial holding
17/12/20 download Created with Sketch. 1.07MB
IMM Immutep Upscales Efti Manufacturing
16/12/20PRICE SENSITIVE download Created with Sketch. 271.36KB
IMM Change in substantial holding
16/12/20 download Created with Sketch. 1.89MB
IMM Operational Update
15/12/20PRICE SENSITIVE download Created with Sketch. 255.39KB
IMM Ceasing to be a substantial holder
15/12/20 download Created with Sketch. 396.12KB
IMM Change in substantial holding
15/12/20 download Created with Sketch. 1.9MB
IMM Appendix 2A
11/12/20 download Created with Sketch. 285.65KB
IMM Webcast slides for AIPAC Phase IIb breast cancer trial
11/12/20 download Created with Sketch. 2.02MB
IMM Immutep's partner EOC pharma to start Ph II trial in MBC
10/12/20PRICE SENSITIVE download Created with Sketch. 280.1KB
IMM Overall Survival data from ph IIb AIPAC breast cancer trial
10/12/20PRICE SENSITIVE download Created with Sketch. 394.58KB
IMM Change in substantial holding from AEF
27/11/20 download Created with Sketch. 212.98KB
IMM Change in substantial holding
27/11/20 download Created with Sketch. 1.07MB
IMM Cleansing Notice
25/11/20 download Created with Sketch. 190.74KB
IMM Change of substantial holding from AEF
24/11/20 download Created with Sketch. 190.66KB
IMM Appendix 2A
24/11/20 download Created with Sketch. 281.34KB
IMM Proposed issue of Securities - IMM
19/11/20PRICE SENSITIVE download Created with Sketch. 25.35KB
IMM Immutep Investor Presentation
19/11/20 download Created with Sketch. 2.26MB
IMM Immutep completes a A$29.6 million placement
19/11/20PRICE SENSITIVE download Created with Sketch. 283.79KB
IMM Immutep expands TACTI-002 Collaboration Trial with MSD
19/11/20PRICE SENSITIVE download Created with Sketch. 242.02KB
IMM Change in substantial holding
18/11/20 download Created with Sketch. 1.9MB
IMM Trading Halt
17/11/20PRICE SENSITIVE download Created with Sketch. 280.45KB
IMM Pause in Trading
17/11/20PRICE SENSITIVE download Created with Sketch. 114.67KB
IMM Encouraging Phase II TACTI-002 data reported at SITC 2020
10/11/20PRICE SENSITIVE download Created with Sketch. 366.98KB
IMM Immutep Announces Australian Patent Grant for IMP701
09/11/20PRICE SENSITIVE download Created with Sketch. 206.9KB
IMM Change of Director's Interest Notice - Grant Chamberlain
06/11/20 download Created with Sketch. 294.56KB
IMM Appendix 3G
06/11/20 download Created with Sketch. 292.87KB
IMM Proposed issue of Securities - IMM
06/11/20 download Created with Sketch. 25.03KB
IMM Immutep to present TACTI-002 phase 2 data at SITC 2020
03/11/20 download Created with Sketch. 285.33KB
IMM Lapse of Unlisted Options
02/11/20 download Created with Sketch. 243.77KB
IMM Immutep enters into a Licence & Collaboration with LabCorp
30/10/20PRICE SENSITIVE download Created with Sketch. 233.43KB
IMM Results of Meeting
27/10/20 download Created with Sketch. 282.66KB
IMM Chairman's AGM Address
27/10/20 download Created with Sketch. 206.53KB
IMM 2020 AGM Presentation
27/10/20PRICE SENSITIVE download Created with Sketch. 1.11MB
IMM COVID-19 phase 2 investigator initiated trial commences
23/10/20PRICE SENSITIVE download Created with Sketch. 287.87KB
IMM Immutep Quarterly Activities Report & Appendix 4C
22/10/20PRICE SENSITIVE download Created with Sketch. 489.39KB
IMM Immutep granted European patent for IMP761
21/10/20PRICE SENSITIVE download Created with Sketch. 224.06KB
IMM Immutep to present AIPAC Overall Survival data at SABCS 2020
19/10/20 download Created with Sketch. 287.17KB
IMM Change in substantial holding
06/10/20 download Created with Sketch. 1.08MB
IMM Change of Director's Interest Notice - Mr Chamberlain
05/10/20 download Created with Sketch. 196.59KB
IMM Change of Director's Interest Notice - Mr Meyers
05/10/20 download Created with Sketch. 204.34KB
IMM Change of Director's Interest Notice - Mr Voigt
05/10/20 download Created with Sketch. 191.84KB
IMM Appendix 2A
02/10/20 download Created with Sketch. 290.32KB
IMM Appendix 3G
02/10/20 download Created with Sketch. 262.09KB
IMM Annual Report filed on Form 20-F with SEC
28/09/20 download Created with Sketch. 758.16KB
IMM Notice of Annual General Meeting/Proxy Form
25/09/20 download Created with Sketch. 1.12MB
IMM Appendix 4G & Corporate Governance Statement
25/09/20 download Created with Sketch. 419.74KB
IMM Annual Report to shareholders
25/09/20 download Created with Sketch. 1.74MB
IMM Immutep reports improving results from INSIGHT-004 trial
18/09/20PRICE SENSITIVE download Created with Sketch. 269.41KB
IMM Improving results from stage 1 of TACTI-002 ph II trial
18/09/20PRICE SENSITIVE download Created with Sketch. 281.8KB
IMM Change in substantial holding
14/09/20 download Created with Sketch. 1.12MB
IMM 2020 AGM & Key Dates
11/09/20 download Created with Sketch. 254.28KB
IMM IMM & Monash Uni receive funding grant for LAG-3 Research
31/08/20PRICE SENSITIVE download Created with Sketch. 264.06KB
IMM New data to be presented at ESMO for eftilagimod alpha
26/08/20 download Created with Sketch. 307.71KB
IMM Appendix 4E & 2020 Full Year Statutory Accounts
25/08/20PRICE SENSITIVE download Created with Sketch. 1.19MB
IMM Recruitment of stage 1 of part B in TACTI-002 study complete
18/08/20PRICE SENSITIVE download Created with Sketch. 243.59KB
IMM Immutep Investor Update
17/08/20 download Created with Sketch. 1.44MB
IMM Immutep granted US patent for eftilagimod alpha
11/08/20PRICE SENSITIVE download Created with Sketch. 206.23KB
IMM Lapse of Unlisted Options
11/08/20 download Created with Sketch. 231.32KB
IMM Change in substantial holding
27/07/20 download Created with Sketch. 1.89MB
IMM Immutep Quarterly Activities Report & Appendix 4C
23/07/20PRICE SENSITIVE download Created with Sketch. 508.74KB
IMM Change in substantial holding
21/07/20 download Created with Sketch. 1.9MB
IMM US patent granted for IMP701 antibody
15/07/20PRICE SENSITIVE download Created with Sketch. 134.22KB
IMM Immutep Completes Recruitment for Part A of TACTI-002 trial
29/06/20PRICE SENSITIVE download Created with Sketch. 239.04KB
IMM Immutep receives A$1,437,826 R&D Tax Incentive
22/06/20PRICE SENSITIVE download Created with Sketch. 228.17KB
IMM Immutep announces improving data from TACTI-002 ph II trial
01/06/20PRICE SENSITIVE download Created with Sketch. 301.55KB
IMM Immutep Reports First Results from INSIGHT-004 Study
01/06/20PRICE SENSITIVE download Created with Sketch. 270.11KB
IMM Immutep receives $3.6M R&D French tax incentive
29/05/20PRICE SENSITIVE download Created with Sketch. 252.82KB
IMM Immutep webcast to present new data from 2020 ASCO meeting
27/05/20 download Created with Sketch. 266.15KB
IMM Becoming a substantial holder from AEF
07/05/20 download Created with Sketch. 228.27KB
IMM Immutep granted Japanese patent for eftilagimod alpha
07/05/20PRICE SENSITIVE download Created with Sketch. 202.35KB
IMM Change in substantial holding
07/05/20 download Created with Sketch. 177.48KB
IMM Cleansing Notice
05/05/20 download Created with Sketch. 190.72KB
IMM Appendix 2A
04/05/20 download Created with Sketch. 280.16KB
IMM Immutep presents at NWR Virtual Small Cap Health Conference
01/05/20 download Created with Sketch. 239.47KB
IMM INSIGHT-004 and TACTI-002 data to be presented at ASCO
30/04/20PRICE SENSITIVE download Created with Sketch. 326.15KB
IMM Proposed issue of Securities - IMM
29/04/20PRICE SENSITIVE download Created with Sketch. 29.45KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
26.0¢
Change
0.000(0.00%)
Mkt cap ! $381.6M
Open High Low Value Volume
26.0¢ 27.0¢ 26.0¢ $408.4K 1.550M

Buyers (Bids)

No. Vol. Price($)
11 406961 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 56625 2
View Market Depth
Last trade - 16.10pm 12/08/2025 (20 minute delay) ?
Last
26.5¢
  Change
0.000 ( 0.38 %)
Open High Low Volume
26.5¢ 26.8¢ 26.0¢ 399186
Last updated 15.59pm 12/08/2025 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.